How small biotech can overcome clinical trial hurdles

How small biotech can overcome clinical trial hurdles

Small biotech companies are responsible for a significant proportion of newly approved medicines, especially for rare diseases. But with limited resources, budget constraints and a lean structure, they face many challenges before they can help patients. Here we look...
Four clinical trial trends to watch in 2023

Four clinical trial trends to watch in 2023

In 2022, the clinical trials industry adjusted to post-pandemic reality, embracing new innovations that emerged from COVID-19. We expect many of these to continue: here we share four trends Siron Clinical will be watching in 2023 and beyond. Looking back, it is clear...
Pediatric Rare Disease Clinical Trials

Pediatric Rare Disease Clinical Trials

There are many challenges to overcome when running a clinical trial, and if pediatric rare disease treatments are being tested, those challenges can be significantly greater. Siron Clinical has expertise in these crossover therapeutic areas – here’s how we overcome...